Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA124891-02S1
Application #
7919655
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Bernhard, Eric J
Project Start
2009-08-01
Project End
2012-07-31
Budget Start
2009-08-01
Budget End
2012-07-31
Support Year
2
Fiscal Year
2009
Total Cost
$494,183
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Biology
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Carbonell, W Shawn; DeLay, Michael; Jahangiri, Arman et al. (2013) ?1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res 73:3145-54
Park, Catherine C; Georgescu, Walter; Polyzos, Aris et al. (2013) Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures. Integr Biol (Camb) 5:681-91
Ahmed, Kazi Mokim; Zhang, Hui; Park, Catherine C (2013) NF-?B regulates radioresistance mediated by ?1-integrin in three-dimensional culture of breast cancer cells. Cancer Res 73:3737-48
Nam, Jin-Min; Ahmed, Kazi M; Costes, Sylvain et al. (2013) ?1-Integrin via NF-?B signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer. Breast Cancer Res 15:R60
Nabavizadeh, Nima; Klifa, Catherine; Newitt, David et al. (2011) Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integr Biol (Camb) 3:490-6
Huang, Catherine; Park, Catherine C; Hilsenbeck, Susan G et al. (2011) ?1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib. Breast Cancer Res 13:R84
Nam, Jin-Min; Onodera, Yasuhito; Bissell, Mina J et al. (2010) Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res 70:5238-48
Weigelt, Britta; Lo, Alvin T; Park, Catherine C et al. (2010) HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat 122:35-43
Nam, Jin-Min; Chung, Yoonsun; Hsu, Howard C et al. (2009) beta1 integrin targeting to enhance radiation therapy. Int J Radiat Biol 85:923-8